Collaborative Drug Discovery Receives SOC 2 Type II Compliance Attestation
Collaborative Drug Discovery has received their SOC 2 Type II Attestation BURLINGAME, CA, UNITED STATES, November 20, 2024 /EINPresswire.com/ -- Independent audit affirms the company’s process excellence that safeguards customer data Collaborative …